发明名称 ABT-263 CRYSTALLINE FORM AND SOLVATE FOR USE IN TREATING Bcl-2 PROTEIN-RELATED DISEASE
摘要 PROBLEM TO BE SOLVED: To provide suitable active pharmaceutical ingredients for pharmaceutical compositions useful in treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer.SOLUTION: A solid crystalline form of ABT-263 is expressed by the following formula, wherein the crystalline form is a solvate comprising ABT-263 free base solvated with an organic solvent. The solvate is selected from the solvates of ethanol/ethyl acetate mixture, 1-propanol, 2-propanol, methanol, benzene, toluene, dioxane/hexanes mixture, methyl acetate/hexanes mixture, chloroform, ethyl acetate, isopropyl acetate, methyl acetate, pyridine, anisole and trifluorotoluene solvates.
申请公布号 JP2015232006(A) 申请公布日期 2015.12.24
申请号 JP20150142670 申请日期 2015.07.17
申请人 ABBVIE INC 发明人 ZHANG GEOFF G Z;PAUL J BRACKEMEYER;NATHANIEL D CATRON;BORSCHARDT THOMAS B
分类号 C07D295/14;A61K31/5377;A61P35/00;A61P35/02;A61P43/00 主分类号 C07D295/14
代理机构 代理人
主权项
地址